Aquaporin A/S maintained financial outlook for full-year 2022. For the year, the company expected revenue of DKK 20 million - DKK 30 million and EBIT (before special items) of negative DKK 105 million - DKK 115 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.3 DKK | +3.53% | +7.67% | -29.78% |
Mar. 25 | London Stocks Retreat Ahead of Final UK GDP Data for Q4 2023 | MT |
Mar. 25 | AstraZeneca Says Ultomiris Gets US FDA Approval to Treat Neuromyelitis Optica Spectrum Disorder | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.78% | 51.21M | |
-7.41% | 23.8B | |
-41.02% | 2.8B | |
0.00% | 2.23B | |
-.--% | 1.98B | |
-13.40% | 1.81B | |
+6.35% | 1.65B | |
-10.87% | 1.57B | |
+21.77% | 1.19B | |
-14.64% | 1.11B |
- Stock
- Equities
- Stock Aquaporin A/S - Nasdaq Copenhagen
- News Aquaporin A/S
- Aquaporin A/S Maintains Financial Outlook for Full-Year 2022